Cognitive and psychomotor effects of paroxetine and sertraline on healthy elderly volunteers

American Journal of Geriatric Psychiatry

Volumn 9, Issue 4, 2001, Pages 429-438

  Furlan, Patricia M ^a   Kallan, Michael J ^a   Ten Have, Thomas ^a   Pollock, Bruce G ^a   Katz, Ira ^a,b   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO; SERTRALINE;

ADULT; AGED; ARTICLE; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HUMAN; MALE; NORMAL HUMAN; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SCORING SYSTEM; SOMNOLENCE; TASK PERFORMANCE;

EID: 84903186507     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200111000-00012     Document Type: Article

References (28)

1. Neurotransmitter receptor and transport binding profile of antidepressants and their metabolites
2. Serum anticholinergicity in older patients treated with paroxetine or nortriptyline
3. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
4. Cognitive and psychomotor effects of antidepressants with emphasis on selective serotonin reuptake inhibitors and the depressed elderly patient
5. A comparative study of acute and subchronic effects of dothiepin, fluoxetine, and placebo on psychomotor and actual driving performance
6. Acute and subchronic effects of paroxetine 20 mg and 40 mg on actual driving, psychomotor performance, and subjective assessments in healthy volunteers
7. Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease
8. Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations
9. Aging and drug interactions, III: Individual and combined effects of cimetidine and cimetidine-and-ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers
10. A review of the metabolism and pharmacokinetics of paroxetine in man
11. Avoiding and managing anticholinergic effects of antidepressants
12. Clinical implications of the pharmacology of serotonin reuptake inhibitors
13. 1 dopamine receptors measured by positron emission tomography
14. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals
15. Reliability and factor analysis of the Epworth Sleepiness Scale
16. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance
17. Chronic use of benzodiazepines and psychomotor and cognitive test performance
18. Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection
19. Some conceptual and statistical issues in analysis of longitudinal psychiatric data
20. Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism
21. Clinical implications of the pharmacology of sertraline
22. Cognitive effects of paroxetine in older depressed patients
23. A Double-blind study of paroxetine compared to fluoxetine in geriatric patients with major depression
24. Does tolerance develop to the sedative and amnesic effects of antidepressants? a comparison of amitriptyline, trazodone, and placebo
25. Paroxetine binding to the rat norepinephrine transporter in vivo
26. A doubleblind comparison of sertraline and fluoxetine in depressed elderly outpatients
27. Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy volunteers over 50 years of age